TLPH Talphera, Inc.
Talphera, Inc. (TLPH) is expected to report earnings on February 11, 2027, after the market close. The consensus earnings estimate is a loss of $0.08 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of -13.0% since its last earnings release on November 12, 2026.
Sign in or subscribe to unlock sentiment, short interest, and technical indicators.
Whisperings™
About Talphera, Inc.
Talphera, Inc. is a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings.
Sector
Healthcare
Industry
Drug Manufacturers/Other
Charts powered in part by Lightweight Charts™ by TradingView.